Follow the people · Insider
Herriot Tabuteau
Herriot Tabuteau files insider transactions with the SEC as a chief executive officer of Axsome Therapeutics (AXSM). We hold 8 disclosed purchases and sales filed since 24 November 2015, 3 of them in the last 90 days.
- Files forAXSM
- Disclosed buys and sells8 in all, 3 in the last 90 days
- Last disclosure7 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 24 November 2015 — 6 August 2026Chief Executive Officer · Axsome Therapeutics (AXSM)95 Form 4 lines · source: SEC Form 4
Everything they disclosed
95 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 45,004 shares of Axsome TherapeuticsSEC Form 47 August 2026Common Stock · traded 5 August 2026 · filed 7 August 2026
- ▼ sold on the open market 45,004 shares of Axsome TherapeuticsSEC Form 47 August 2026Common Stock · traded 5 August 2026 · filed 7 August 2026
- exercised options over 4,660 shares of Axsome TherapeuticsSEC Form 47 August 2026Common Stock · traded 6 August 2026 · filed 7 August 2026
- ▼ sold on the open market 4,660 shares of Axsome TherapeuticsSEC Form 47 August 2026Common Stock · traded 6 August 2026 · filed 7 August 2026
- exercised options over 45,004 shares of Axsome Therapeutics (a derivative holding)SEC Form 47 August 2026Stock Option (Right to Buy) · traded 5 August 2026 · filed 7 August 2026
- exercised options over 4,660 shares of Axsome Therapeutics (a derivative holding)SEC Form 47 August 2026Stock Option (Right to Buy) · traded 6 August 2026 · filed 7 August 2026
- exercised options over 49,666 shares of Axsome TherapeuticsSEC Form 41 July 2026Common Stock · traded 1 July 2026 · filed 1 July 2026
- ▼ sold on the open market 49,666 shares of Axsome TherapeuticsSEC Form 41 July 2026Common Stock · traded 1 July 2026 · filed 1 July 2026
- exercised options over 49,666 shares of Axsome Therapeutics (a derivative holding)SEC Form 41 July 2026Stock Option (Right to Buy) · traded 1 July 2026 · filed 1 July 2026
- exercised options over 49,670 shares of Axsome TherapeuticsSEC Form 49 June 2026Common Stock · traded 9 June 2026 · filed 9 June 2026
- ▼ sold on the open market 49,670 shares of Axsome TherapeuticsSEC Form 49 June 2026Common Stock · traded 9 June 2026 · filed 9 June 2026
- exercised options over 49,670 shares of Axsome Therapeutics (a derivative holding)SEC Form 49 June 2026Stock Option (Right to Buy) · traded 9 June 2026 · filed 9 June 2026
- was granted 24,081 shares of Axsome Therapeutics (a derivative holding)SEC Form 423 April 2026Performance Stock Units · traded 21 April 2026 · filed 23 April 2026
- was granted 54,623 shares of Axsome Therapeutics (a derivative holding)SEC Form 427 February 2026Restricted Stock Units · traded 26 February 2026 · filed 27 February 2026
- was granted 54,623 shares of Axsome Therapeutics (a derivative holding)SEC Form 427 February 2026Restricted Stock Units · traded 26 February 2026 · filed 27 February 2026
- exercised options over 32,410 shares of Axsome TherapeuticsSEC Form 42 February 2026Common Stock · traded 2 February 2026 · filed 2 February 2026
- ▼ sold on the open market 32,410 shares of Axsome TherapeuticsSEC Form 42 February 2026Common Stock · traded 2 February 2026 · filed 2 February 2026
- exercised options over 32,410 shares of Axsome Therapeutics (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 2 February 2026 · filed 2 February 2026
- exercised options over 32,410 shares of Axsome Therapeutics (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 2 February 2026 · filed 2 February 2026
- exercised options over 32,410 shares of Axsome TherapeuticsSEC Form 42 February 2026Common Stock · traded 2 February 2026 · filed 2 February 2026
- ▼ sold on the open market 32,410 shares of Axsome TherapeuticsSEC Form 42 February 2026Common Stock · traded 2 February 2026 · filed 2 February 2026
- exercised options over 78,703 shares of Axsome TherapeuticsSEC Form 47 January 2026Common Stock · traded 5 January 2026 · filed 7 January 2026
- ▼ sold on the open market 78,703 shares of Axsome TherapeuticsSEC Form 47 January 2026Common Stock · traded 5 January 2026 · filed 7 January 2026
- exercised options over 29,450 shares of Axsome TherapeuticsSEC Form 47 January 2026Common Stock · traded 6 January 2026 · filed 7 January 2026
- exercised options over 78,703 shares of Axsome Therapeutics (a derivative holding)SEC Form 47 January 2026Stock Option (Right to Buy) · traded 5 January 2026 · filed 7 January 2026
- exercised options over 29,450 shares of Axsome Therapeutics (a derivative holding)SEC Form 47 January 2026Stock Option (Right to Buy) · traded 6 January 2026 · filed 7 January 2026
- exercised options over 31,261 shares of Axsome Therapeutics (a derivative holding)SEC Form 47 January 2026Stock Option (Right to Buy) · traded 7 January 2026 · filed 7 January 2026
- ▼ sold on the open market 29,450 shares of Axsome TherapeuticsSEC Form 47 January 2026Common Stock · traded 6 January 2026 · filed 7 January 2026
- exercised options over 31,261 shares of Axsome TherapeuticsSEC Form 47 January 2026Common Stock · traded 7 January 2026 · filed 7 January 2026
- ▼ sold on the open market 31,261 shares of Axsome TherapeuticsSEC Form 47 January 2026Common Stock · traded 7 January 2026 · filed 7 January 2026
- exercised options over 78,703 shares of Axsome Therapeutics (a derivative holding)SEC Form 47 January 2026Stock Option (Right to Buy) · traded 5 January 2026 · filed 7 January 2026
- exercised options over 29,450 shares of Axsome Therapeutics (a derivative holding)SEC Form 47 January 2026Stock Option (Right to Buy) · traded 6 January 2026 · filed 7 January 2026
- exercised options over 78,703 shares of Axsome TherapeuticsSEC Form 47 January 2026Common Stock · traded 5 January 2026 · filed 7 January 2026
- ▼ sold on the open market 78,703 shares of Axsome TherapeuticsSEC Form 47 January 2026Common Stock · traded 5 January 2026 · filed 7 January 2026
- exercised options over 29,450 shares of Axsome TherapeuticsSEC Form 47 January 2026Common Stock · traded 6 January 2026 · filed 7 January 2026
- ▼ sold on the open market 29,450 shares of Axsome TherapeuticsSEC Form 47 January 2026Common Stock · traded 6 January 2026 · filed 7 January 2026
- exercised options over 31,261 shares of Axsome TherapeuticsSEC Form 47 January 2026Common Stock · traded 7 January 2026 · filed 7 January 2026
- ▼ sold on the open market 31,261 shares of Axsome TherapeuticsSEC Form 47 January 2026Common Stock · traded 7 January 2026 · filed 7 January 2026
- exercised options over 31,261 shares of Axsome Therapeutics (a derivative holding)SEC Form 47 January 2026Stock Option (Right to Buy) · traded 7 January 2026 · filed 7 January 2026
- exercised options over 49,252 shares of Axsome Therapeutics (a derivative holding)SEC Form 44 December 2025Stock Option (Right to Buy) · traded 2 December 2025 · filed 4 December 2025
- exercised options over 20,163 shares of Axsome Therapeutics (a derivative holding)SEC Form 44 December 2025Stock Option (Right to Buy) · traded 3 December 2025 · filed 4 December 2025
- exercised options over 10,558 shares of Axsome Therapeutics (a derivative holding)SEC Form 44 December 2025Stock Option (Right to Buy) · traded 4 December 2025 · filed 4 December 2025
- exercised options over 49,252 shares of Axsome TherapeuticsSEC Form 44 December 2025Common Stock · traded 2 December 2025 · filed 4 December 2025
- ▼ sold on the open market 49,252 shares of Axsome TherapeuticsSEC Form 44 December 2025Common Stock · traded 2 December 2025 · filed 4 December 2025
- exercised options over 20,163 shares of Axsome TherapeuticsSEC Form 44 December 2025Common Stock · traded 3 December 2025 · filed 4 December 2025
- ▼ sold on the open market 20,163 shares of Axsome TherapeuticsSEC Form 44 December 2025Common Stock · traded 3 December 2025 · filed 4 December 2025
- exercised options over 10,558 shares of Axsome TherapeuticsSEC Form 44 December 2025Common Stock · traded 4 December 2025 · filed 4 December 2025
- ▼ sold on the open market 10,558 shares of Axsome TherapeuticsSEC Form 44 December 2025Common Stock · traded 4 December 2025 · filed 4 December 2025
- exercised options over 91,705 shares of Axsome Therapeutics (a derivative holding)SEC Form 45 November 2025Stock Option (Right to Buy) · traded 3 November 2025 · filed 5 November 2025
- exercised options over 50,459 shares of Axsome Therapeutics (a derivative holding)SEC Form 45 November 2025Stock Option (Right to Buy) · traded 4 November 2025 · filed 5 November 2025
- exercised options over 21,775 shares of Axsome Therapeutics (a derivative holding)SEC Form 45 November 2025Stock Option (Right to Buy) · traded 5 November 2025 · filed 5 November 2025
- exercised options over 91,705 shares of Axsome TherapeuticsSEC Form 45 November 2025Common Stock · traded 3 November 2025 · filed 5 November 2025
- ▼ sold on the open market 91,705 shares of Axsome TherapeuticsSEC Form 45 November 2025Common Stock · traded 3 November 2025 · filed 5 November 2025
- exercised options over 50,459 shares of Axsome TherapeuticsSEC Form 45 November 2025Common Stock · traded 4 November 2025 · filed 5 November 2025
- ▼ sold on the open market 50,459 shares of Axsome TherapeuticsSEC Form 45 November 2025Common Stock · traded 4 November 2025 · filed 5 November 2025
- exercised options over 21,775 shares of Axsome TherapeuticsSEC Form 45 November 2025Common Stock · traded 5 November 2025 · filed 5 November 2025
- ▼ sold on the open market 21,775 shares of Axsome TherapeuticsSEC Form 45 November 2025Common Stock · traded 5 November 2025 · filed 5 November 2025
- exercised options over 19,220 shares of Axsome Therapeutics (a derivative holding)SEC Form 48 October 2025Stock Option (Right to Buy) · traded 6 October 2025 · filed 8 October 2025
- exercised options over 13,390 shares of Axsome Therapeutics (a derivative holding)SEC Form 48 October 2025Stock Option (Right to Buy) · traded 7 October 2025 · filed 8 October 2025
- exercised options over 12,774 shares of Axsome Therapeutics (a derivative holding)SEC Form 48 October 2025Stock Option (Right to Buy) · traded 8 October 2025 · filed 8 October 2025
- exercised options over 19,220 shares of Axsome TherapeuticsSEC Form 48 October 2025Common Stock · traded 6 October 2025 · filed 8 October 2025
- ▼ sold on the open market 19,220 shares of Axsome TherapeuticsSEC Form 48 October 2025Common Stock · traded 6 October 2025 · filed 8 October 2025
- exercised options over 13,390 shares of Axsome TherapeuticsSEC Form 48 October 2025Common Stock · traded 7 October 2025 · filed 8 October 2025
- ▼ sold on the open market 13,390 shares of Axsome TherapeuticsSEC Form 48 October 2025Common Stock · traded 7 October 2025 · filed 8 October 2025
- exercised options over 12,774 shares of Axsome TherapeuticsSEC Form 48 October 2025Common Stock · traded 8 October 2025 · filed 8 October 2025
- ▼ sold on the open market 12,774 shares of Axsome TherapeuticsSEC Form 48 October 2025Common Stock · traded 8 October 2025 · filed 8 October 2025
- exercised options over 27,907 shares of Axsome Therapeutics (a derivative holding)SEC Form 416 September 2025Stock Option (Right to Buy) · traded 12 September 2025 · filed 16 September 2025
- exercised options over 15,254 shares of Axsome Therapeutics (a derivative holding)SEC Form 416 September 2025Stock Option (Right to Buy) · traded 15 September 2025 · filed 16 September 2025
- exercised options over 19,719 shares of Axsome Therapeutics (a derivative holding)SEC Form 416 September 2025Stock Option (Right to Buy) · traded 16 September 2025 · filed 16 September 2025
- exercised options over 27,907 shares of Axsome TherapeuticsSEC Form 416 September 2025Common Stock · traded 12 September 2025 · filed 16 September 2025
- ▼ sold on the open market 27,907 shares of Axsome TherapeuticsSEC Form 416 September 2025Common Stock · traded 12 September 2025 · filed 16 September 2025
- exercised options over 15,254 shares of Axsome TherapeuticsSEC Form 416 September 2025Common Stock · traded 15 September 2025 · filed 16 September 2025
- ▼ sold on the open market 15,254 shares of Axsome TherapeuticsSEC Form 416 September 2025Common Stock · traded 15 September 2025 · filed 16 September 2025
- exercised options over 19,719 shares of Axsome TherapeuticsSEC Form 416 September 2025Common Stock · traded 16 September 2025 · filed 16 September 2025
- ▼ sold on the open market 19,719 shares of Axsome TherapeuticsSEC Form 416 September 2025Common Stock · traded 16 September 2025 · filed 16 September 2025
- was granted 28,887 shares of Axsome Therapeutics (a derivative holding)SEC Form 425 February 2025Employee Stock Option (Right to Buy) · traded 21 February 2025 · filed 25 February 2025
- was granted 28,609 shares of Axsome Therapeutics (a derivative holding)SEC Form 425 February 2025Restricted Stock Units · traded 21 February 2025 · filed 25 February 2025
- was granted 28,609 shares of Axsome Therapeutics (a derivative holding)SEC Form 425 February 2025Performance Stock Units · traded 24 February 2025 · filed 25 February 2025
- was granted 87,192 shares of Axsome Therapeutics (a derivative holding)SEC Form 429 February 2024Employee Stock Option (Right to Buy) · traded 27 February 2024 · filed 29 February 2024
- was granted 47,886 shares of Axsome Therapeutics (a derivative holding)SEC Form 429 February 2024Restricted Stock Units · traded 27 February 2024 · filed 29 February 2024
- was granted 110,032 shares of Axsome Therapeutics (a derivative holding)SEC Form 46 March 2023Employee Stock Option (Right to Buy) · traded 2 March 2023 · filed 6 March 2023
- was granted 62,400 shares of Axsome Therapeutics (a derivative holding)SEC Form 46 March 2023Restricted Stock Units · traded 2 March 2023 · filed 6 March 2023
- was granted 209,655 shares of Axsome Therapeutics (a derivative holding)SEC Form 48 March 2022Employee Stock Option (Right to Buy) · traded 4 March 2022 · filed 8 March 2022
- was granted 110,861 shares of Axsome Therapeutics (a derivative holding)SEC Form 48 March 2022Restricted Stock Units · traded 4 March 2022 · filed 8 March 2022
- was granted 97,155 shares of Axsome Therapeutics (a derivative holding)SEC Form 49 March 2021Employee Stock Option (Right to Buy) · traded 5 March 2021 · filed 9 March 2021
- was granted 51,715 shares of Axsome Therapeutics (a derivative holding)SEC Form 49 March 2021Restricted Stock Units · traded 5 March 2021 · filed 9 March 2021
- was granted 168,776 shares of Axsome Therapeutics (a derivative holding)SEC Form 419 March 2020Employee Stock Option (Right to Buy) · traded 17 March 2020 · filed 19 March 2020
- was granted 51,691 shares of Axsome Therapeutics (a derivative holding)SEC Form 419 March 2020Restricted Stock Units · traded 17 March 2020 · filed 19 March 2020
- was granted 68,837 shares of Axsome Therapeutics (a derivative holding)SEC Form 415 October 2019Employee Stock Option (Right to Buy) · traded 10 October 2019 · filed 15 October 2019
- was granted 319,212 shares of Axsome Therapeutics (a derivative holding)SEC Form 421 March 2019Employee Stock Option (Right to Buy) · traded 19 March 2019 · filed 21 March 2019
- was granted 187,628 shares of Axsome Therapeutics (a derivative holding)SEC Form 45 April 2018Employee Stock Option (Right to Buy) · traded 12 March 2018 · filed 5 April 2018
- was granted 149,000 shares of Axsome Therapeutics (a derivative holding)SEC Form 417 March 2017Employee Stock Option (Right to Buy) · traded 15 March 2017 · filed 17 March 2017
- was granted 524,000 shares of Axsome Therapeutics (a derivative holding)SEC Form 41 June 2016Employee Stock Option (Right to Buy) · traded 27 May 2016 · filed 1 June 2016
- converted 7,229 shares of Axsome TherapeuticsSEC Form 424 November 2015Common Stock · traded 24 November 2015 · filed 24 November 2015
- was granted 7,229 shares of Axsome Therapeutics (a derivative holding)SEC Form 424 November 20158% Convertible Note · traded 24 November 2015 · filed 24 November 2015
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.